spot_img
HomeAbout Parand DarouAbout Parand Darou

About Parand Darou

As a knowledge-based company, Parand Darou pharmaceutical company started its activity in 2006 with the production of Narcotic APIs. Parand Darou Company is the second company in the private sector that received the license to produce narcotic products from the Food and Drug Organization of Iran. Extracting the Opioid raw materials, manufactured effective medicinal substances such as Codeine Phosphate, Noscapine, Thebaine, Papaverine and Oxycodone, in addition to meet the needs of domestic customers, it has exported its products to the world markets. In 2019, the company established a syrup line and received a GMP certificate and launched the production cycle of narcotic FDF as well. In July 2022, Kimyagaran Group (public stock) purchased the management shares of Parand Darou Pharmaceutical Company and aims to create a turning point in the growth, development and excellence of the company by cooperating with the expert and experienced management team.

Dr. Mohammad Reza Mousavi
Education: PhD in Strategic Management, University of Tehran
Experience: Approximately 28 years in the pharmaceutical industry
Titles:

  • CEO and Principal Shareholder of Kimiyagaran Emrooz Company
  • Vice Chairman and Member of the Board of Directors of the Syndicate of Medium and API
  • Chairman of the Board of Directors of Parand Darou Company
Engineer Hamidreza Alipour
Education:

  • DBA in Advanced Business Management (Equivalent to PhD)
  • MBA in Pharmaceutical Business Management (Equivalent to Master’s degree)
  • Bachelor’s degree in Applied Chemistry from the University of Tabriz

Work Experience and Titles:

  • 29 years of managerial work and board membership in pharmaceutical companies
Masoud Saraei
Position: Factory Manager
Education: Master’s degree
Years of Executive Experience: 18 years
Some Previous Positions:

  1. Temad Pharmaceutical Company
  2. Alloy Welding Company
Yousef Bazghi
Position: Commercial Manager
Education: Master’s degree
Years of Executive Experience: 30 years
Some Previous Positions:

  1. Razi Distribution Company
  2. Iran Hormone Company
  3. Iran Injectable and Pharmaceutical Products
  4. Darou Pakhsh Trading Company
  5. Dana Pharmaceutical Company
  6. Temad Pharmaceutical Company
  7. Faran Shimi Pharmaceutical Company
Hashem Ashna-Dar
Position: Financial Manager
Education: Master’s degree
Years of Executive Experience: 25 years
Some Previous Positions:

  1. Zagros Pharmaceutical Ingredients Company
  2. Shafa Health and Pharmaceutical Laboratories
  3. Yasin Pharmaceutical Group
  4. Darou Pakhsh Chemical Pharmaceutical Company
Hossein Beigliri
Position: Quality Assurance Manager
Education: Master’s degree
Years of Executive Experience: 15 years
Some Previous Positions:

  1. Temad Pharmaceutical Company
  2. CinnaGen and Nano Alvand Pharmaceutical Companies
  3. Iran Daru Pharmaceutical Company
  4. Iran Najo Pharmaceutical Company
Abolfazl Hajipour
Position: Production Manager
Education: Master’s degree
Years of Executive Experience: 17 years
Some Previous Positions:

  1. Iran Maye Company
  2. Pharmaceutical Raw Materials Production Company (Temad)
Roqieh Davaasaz
Position: Final Products Technical Manager
Education: PhD in Pharmacy
Years of Executive Experience: 35 years
Some Previous Positions:

  1. Raziak Company (30 years)
  2. Parand Darou Pharmaceutical Company
Mehdi Ghashghaei
Position: Technical and Engineering Manager
Education: Master’s degree
Years of Executive Experience: 20 years
Some Previous Positions:

  1. Temad Pharmaceutical Company
  2. Alborz Pharmed Company
Roonak Ekhtiari
Position: Planning and Warehousing Manager
Education: Master’s degree
Years of Executive Experience: 13 years
Some Previous Positions:

  1. Medava Pharmaceutical Company
  2. Mofid Pharmaceutical Company
  3. Iran Hormone Pharmaceutical Company
  4. Ani Darman Pharmaceutical Company

NOW

♦♦ 2022
Acquisition of 67% Shares
Acquisition of the controlling shares (67% of the shares) of Parand Darou by Kimiyagaran Emrooz Chemical Industries Company, leading to a management change in the company.

♦♦♦ 2019
Capital Increase
The latest capital increase of the company from 48 billion Rials to 55 billion Rials.

♦♦♦♦ 2018
Establishment of Syrup Production Line
The establishment of a syrup production line and Parand Darou’s entry into the production of final narcotic products, transforming into a pharmaceutical company.

♦♦♦♦♦ 2016
Transformation into a Knowledge-Based Company
Parand Darou joined the ranks of knowledge-based companies in 2016.
♦♦♦♦♦♦ 2006
Establishment of the Company Parand Darou Pharmaceutical API Manufacturing Company was established in 2006 and registered with the Companies and Non-Commercial Institutes Registration Office of Saveh.

spot_img

latest articles

explore more

LEAVE A REPLY

Please enter your comment!
Please enter your name here